The Journal of Neuroscience, March 22, 2006, 26(12):3169-3181; doi:10.1523/JNEUROSCI.5120-05.2006
Previous Article | Next Article 
Behavioral/Systems/Cognitive
Disruption of Glycine Transporter 1 Restricted to Forebrain Neurons Is Associated with a Procognitive and Antipsychotic Phenotypic Profile
Benjamin K. Yee,1
Ela Balic,2
Philipp Singer,1
Cornelia Schwerdel,2
Thomas Grampp,2
Laetitia Gabernet,2
Irene Knuesel,1
Dietmar Benke,2
Joram Feldon,1
Hanns Mohler,2,3 and
Detlev Boison4
1Laboratory of Behavioral Neurobiology, Swiss Federal Institute of Technology, 8603 Schwerzenbach, Switzerland, 2Institute of Pharmacology and Toxicology, University of Zurich, 8057 Zurich, Switzerland, 3Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology and Collegium Helveticum, 8093 Zurich, Switzerland, and 4R. S. Dow Neurobiology Laboratories, Legacy Research, Portland, Oregon 97232
Correspondence should be addressed to Dr. Detlev Boison, Dow Neurobiology Laboratories, Legacy Research, 1225 Northeast 2nd Avenue, Portland, OR 97232. Email: dboison{at}downeurobiology.org
The NMDA receptor is thought to play a central role in some forms of neuronal plasticity, including the induction of long-term potentiation. NMDA receptor hypofunction can result in mnemonic impairment and has been implicated in the cognitive symptoms of schizophrenia. The activity of NMDA receptors is controlled by its endogenous coagonist glycine, and a local elevation of glycine levels is expected to enhance NMDA receptor function. Here, we achieved this by the generation of a novel mouse line (CamKII
Cre;Glyt1tm1.2fl/fl) with a neuron and forebrain selective disruption of glycine transporter 1 (GlyT1). The mutation led to a significant reduction of GlyT1 and a corresponding reduction of glycine reuptake in forebrain samples, without affecting NMDA receptor expression. NMDA (but not AMPA) receptor-evoked EPSCs recorded in hippocampal slices of mutant mice were 2.5 times of those recorded in littermate controls, suggesting that neuronal GlyT1 normally assumes a specific role in the regulation of NMDA receptor responses. Concomitantly, the mutants were less responsive to phencyclidine than controls. The mutation enhanced aversive Pavlovian conditioning without affecting spontaneous anxiety-like behavior in the elevated plus maze and augmented a form of attentional learning called latent inhibition in three different experimental paradigms: conditioned freezing, conditioned active avoidance, conditioned taste aversion. The CamKII
Cre;Glyt1tm1.2fl/fl mouse model thus suggests that augmentation of forebrain neuronal glycine transmission is promnesic and may also offer an effective therapeutic intervention against the cognitive and attentional impairments characteristic of schizophrenia.
Key words: glycine transporter 1; NMDA receptor; conditional knock-out mice; latent inhibition; selective attention; learning; schizophrenia
Received Dec. 1, 2005;
revised Jan. 12, 2006;
accepted Feb. 6, 2006.
Correspondence should be addressed to Dr. Detlev Boison, Dow Neurobiology Laboratories, Legacy Research, 1225 Northeast 2nd Avenue, Portland, OR 97232. Email: dboison{at}downeurobiology.org